Skin climacteric aging and hormone replacement therapy.

Biomechanics; Climacteric/physiology; Estrogen Replacement Therapy/adverse effects; Female; Humans; Menopause/physiology; Microcirculation/physiology; Middle Aged; Skin/blood supply; Skin Aging

Abstract :

[en] A gender perspective is indispensable for a full understanding of aging. Menopause is a turning point in women's lives. In addition to the effects of chronological aging, sunlight exposure, and other environmental and endogenous stimuli, the climacteric appears to exert some dramatic consequences on skin biology and aspect. The epidermis may become xerotic and exhibit altered functions. The dermis thins out and its elasticity decreases in concert with the decline in bone mass. The skin microcirculation is impaired. These aspects are some of the better worked-out changes of the climacteric, which in turn seem to be stabilized or in part reversible with hormone replacement therapy (HRT). The HRT effect on menopause consequences on hair growth and sebum production is less impressive. This review summarizes some important impacts of the climacteric on skin, and highlights the benefits of HRT that may influence cosmetic dermatology.

Disciplines :

Dermatology

Author, co-author :

Quatresooz, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Pierard, Claudine ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Gaspard, Ulysse ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique

Pierard, Gérald ; Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie

Language :

English

Title :

Skin climacteric aging and hormone replacement therapy.

Publication date :

2006

Journal title :

Journal of Cosmetic Dermatology

ISSN :

1473-2130

eISSN :

1473-2165

Publisher :

Blackwell Publishing

Volume :

Issue :

Pages :

3-8

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 13 February 2009

Statistics

Number of views

87 (0 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288: 49-57.
Writing Group for the Women's Health Initiative Investigations. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33.
Viscoli CM, Brass LM, Kerman WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen replacement therapy after ischemic stroke. N Engl J Med 2001; 345: 1243-9.
The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004; 291: 1701-12.
The American College of Obstetricians and Gynecologists. Hormone therapy. Obstet Gynecol 2004; 104 (S4): S1-131.
Scarabin PY, Oger E, Plu Bureau G. Differential association of oral and transdermal estrogen replacement therapy with venous thromboembolism risk. Lancet 2003; 362: 428-32.
Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer 2004; 114 (3): 448-54.
Bolognia JL. Aging skin. Am J Med 1995; 98: 99-103.
Piérard GE. The quandary of climacteric skin aging. Dermatology 1996; 193: 273-4.
Piérard GE. Aging across the life span: Time to think again. J Cosmet Dermatol 2004; 3: 50-3.
Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol 1987; 123: 1638-43.
Brincat M, Moniz CJ, Studd JW, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985;92: 256-9.
Brincat M, Kabalan S, Studd JW, Moniz CF, de Trafford J, Montgomery J. A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal women. Obstet Gynecol 1987; 70: 840-5.
Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism of skin collagen. Maturitas 1999; 33: 139-47.
Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990; 30: 97-100.
Sawaya ME, Penneys NS. Immunohistochemical distribution of aromatase and 3B-hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland. J Cutan Pathol 1992; 19: 309-14.
Simpson ER, Mahendroo MS, Means GD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994; 15: 342-55.
Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE. Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab 1997; 82: 70-4.
Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette F. Does hormonal skin aging exist? A study of the influence of different hormone therapy regiments on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 1996; 193: 289-94.
Dunn LB, Damesyn M, Moore AA, Reuben DB, Greendale GA. Does estrogen prevent skin aging? Results from the first National Health and Nutrition Examination Survey (NHANES I). Arch Dermatol 1997; 133: 339-42.
Raine-Fenning NJ, Sant RA, Brincat MP. HRT in the new millennium. Contemp. Clin Gynecol Obstet 2001; 1: 7-23.
Raine-Fenning NJ, Brincat M, Muscat-Baron Y. Skin aging and menopause: implications for treatment. Am J Clin Dermatol 2003; 4: 371-8.
Brincat M, Versi E, O'Dowd T, et al. Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas 1987; 9: 1-5.
Brincat M, Versi E, Moniz CF, Magos A, de Trafford J, Studd JW. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987; 70: 123-7.
Savvas M, Bishop J, Laurent G, Watson N, Studd J. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br J Obstet Gynaecol 1993; 100: 154-6.
Maheux R, Naud F, Rioux M, et al. A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol 1994; 170: 642-69.
Varila E, Rantala I, Oikarinen A, et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 1995; 102: 985-9.
Schmidt JB, Binder M, Demschik G, Biegmayer C, Reiner A. Treatment of skin aging with topical estrogens. Int J Dermatol 1996; 35: 669-74.
Cortes-Gallegos V, Villanueva GL, Sojo-Aranda I, Santa Cruz FJ. Inverted skin changes induced by estrogen and estrogen/glucocorticoid on aging dermis. Gynecol Endocrinol 1996; 10: 125-8.
Sauerbronn AV, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA. The effect of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000; 68: 35-41.
Sator PG, Schmidt JB, Sator MO, Huber JC, Honigsmann H. The influence of hormone replacement therapy on skin aging: A pilot study. Maturitas 2001; 39: 43-55.
Varila E, Sievanen H, Vuori I, Oksanen H, Punnonen R. Limited value of ultrasound measured skin thickness in predicting bone mineral density in peri- and postmenopausal women. Maturitas 1995; 21: 45-9.
Haapasaari KM, Raudaskoski T, Kallioinen M, et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas 1997; 27: 153-62.
Oikarinen A. Systemic estrogens have no conclusive beneficial effect on human skin connective tissue. Acta Obstet Gynecol Scand 2000; 79: 250-4.
Henry F, Piérard-Franchimont C, Cauwenbergh G, Pierard GE. Age-related changes in facial skin contours and rheology. J Am Geriatr Soc 1997; 45: 220-2.
Piérard GE, Henry F, Castelli D, Ries G. Aging and rheological properties of facial skin in women. Gerontology 1998; 44: 159-61.
Hermanns-LêT, Uhoda I, Smitz S, Piérard GE. Skin tensile properties revisited during aging. Where now, where next? J Cosmet Dermatol 2004; 3: 35-40.
Piérard GE, Uhoda I, Piérard-Franchimont C. From skin microrelief to wrinkles. An area ripe for investigations. J Cosmet Dermatol 2003; 2: 21-8.
Piérard GE, Letawe C, Dowlati A, Piérard-Franchimont C. Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995; 43: 662-5.
Piérard-Franchimont C, Cornil F, Dehavay J, Letot B, Deleixhe-Mauhin F, Piérard GE. Climacteric skin aging of the face. A prospective longitudinal intent-to-treat trial on the effect of oral hormone replacement therapy. Maturitas 1999; 32: 87-93.
Piérard GE, Henry F, Piérard-Franchimont C. Comparative effect of short-term topical tretinoin and glycolic acid on mechanical properties of photodamaged facial skin in HRT-treated menopausal women. Maturitas 1996; 23: 273-7.
Castelo-Branco C, Figueras F, Martinez de Osaba MJ, Vanrell JA. Facial wrinkling in postmenopausal women. Effects of smoking status and hormone replacement therapy. Maturitas 1998; 29: 75-86.
Nilas L, Christiansen C. Rates of bone loss in normal women: Evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 1988; 18: 529-34.
Chappard D, Alexandre C, Robert JM, Riffat G. Relationships between bone and skin atrophies during aging. Acta Anat 1991; 141: 239-44.
Castello-Branco C, Pons F, Gratacos E, Fortuny A, Vanrell JA, Gonzales-Merlo J. Relationship between skin collagen and bone changes during aging. Maturitas 1994; 18: 199-206.
Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999; 33: 239-47.
Shah MG, Maibach HI. Estrogen and skin: An overview. Am J Clin Dermatol 2001; 2: 143-50.
Brincat M, Moniz CF, Kabalan S, et al. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynaecol 1987; 94: 126-9.
Piérard GE, Vanderplaetsen S, Piérard-Franchimont C. Comparative effect of hormone replacement therapy on bone mass density and skin tensile properties. Maturitas 2001; 40: 221-7.
Piérard GE, Piérard-Franchimont C, Vanderplaetsen S, Franchimont N, Gaspard U, Malaise M. Relationships between bone mass density and tensile strength of the skin in women. Eur J Clin Invest 2001; 31: 731-5.
Henry F, Quatresooz P, Valverde-Lopez JC, Piérard GE. Blood vessel changes during pregnancy. A review. J Cosmet Dermatol, in press.
Haenggi W, Linder HR, Birkhauser MH, Schneider H. Microscopic findings of the nail-fold capillaries-dependence on menopausal status and hormone replacement therapy. Maturitas 1995; 22: 37-46.
Brooks-Asplung EM, Kenney WL. Chronic hormone replacement therapy does not alter resting or maximal skin blood flow. J Appl Physiol 1998; 85: 505-10.
Brooks EM, Morgan AL, Pierzga JM, et al. Chronic hormone replacement therapy alters thermoregulatory and vasomotor function in postmenopausal women. J Appl Physiol 1997; 83: 477-84.
Ginsburg J, Hardiman P, O'Reilly B. Peripheral blood flow in menopausal women who have hot flushes and in those who do not. Br Med J 1989; 298: 1488-90.
Brincat M, de Trafford JC, Lafferty K, Studd JW. Peripheral vasomotor control and menopausal flushing. A preliminary report. Br J Obstet Gynaecol 1984; 91: 1107-10.
Margolis DJ, Knauss J, Bilker W. Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers. Lancet 2002; 359: 675-7.
Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999; 155: 1137-46.
Piérard-Franchimont C, Letawe C, Goffin V, Piérard GE. Skin water-holding capacity and transdermal estrogen therapy for menopause: A pilot study. Maturitas 1995; 22: 151-4.
Paquet F, Piérard-Franchimont C, Fumal I, Goffin V, Paye MGE, Piérard GE. Sensitive skin at menopause: Dew point and electrometric properties of the stratum corneum. Maturitas 1998; 28: 221-7.
Quatresooz P, Petit L, Uhoda I, Piérard-Franchimont C, Piérard GE. Mosaic subclinical melanoderma. An Achilles heel for UV-related epidermal carcinogenesis. Int J Oncol 2004; 25: 1763-8.
Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol 2005; 25: 55-60.
Dören M. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 2001; 75: 554-9.
Roux C. Randomised, double-masked, 2 years comparison of tibolone with 17β estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis Int 2002; 13: 241-8.
Piérard-Franchimont C, Piérard GE. Post-menopausal aging of the sebaceous follicle. A comparison between women receiving hormone replacement therapy or not. Dermatology 2002; 204: 17-22.